Exact Mass: 610.0832

Exact Mass Matches: 610.0832

Found 157 metabolites which its exact mass value is equals to given mass value 610.0832, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Prodelphinidin B

8-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

Prodelphinidin B is found in alcoholic beverages. Prodelphinidin B is isolated from beer Prodelphinidin is a name for the polymeric tannins composed of gallocatechin (Porter, 1992). Isolated from beer

Cyanidin 3-(6-caffeylglucoside)

C30H26O14 (610.1322)

(-)-Epigallocatechin 3,3'-di-gallate

(2R,3R)-2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(-)-Epigallocatechin 3,3-di-gallate is found in tea. (-)-Epigallocatechin 3,3-di-gallate is isolated from green tea (Thea sinensis). Isolated from green tea (Thea sinensis). Epigallocatechin 3,3-digallate is found in tea.

6'-O-Caffeoylastragalin

(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid

C30H26O14 (610.1322)

6-O-Caffeoylastragalin is found in green vegetables. 6-O-Caffeoylastragalin is a constituent of young bracken fronds (Pteridium aquilinium)

(-)-Epigallocatechin 3,5-di-gallate

(2R,3R)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(-)-Epigallocatechin 3,5-di-gallate is found in tea. (-)-Epigallocatechin 3,5-di-gallate is isolated from tea (Thea sinensis). Isolated from tea (Thea sinensis). Epigallocatechin 3,5-digallate is found in tea.

Theasinensin C

(2R,3R)-2-(3,4,5-trihydroxy-2-{2,3,4-trihydroxy-6-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl]phenyl}phenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

Theasinensin E is found in tea. Theasinensin E is from oolong tea Camellia sinensis var. viridis. From oolong tea Camellia sinensis variety viridis. Theasinensin E is found in tea.

(6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

6'-Caffeoylisoorientin

{6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-6-yl]-3,4,5-trihydroxyoxan-2-yl}methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid

C30H26O14 (610.1322)

6-Caffeoylisoorientin is found in fruits. 6-Caffeoylisoorientin is a constituent of Vitex agnus-castus (agnus castus). Constituent of Vitex agnus-castus (agnus castus). 6-Caffeoylisoorientin is found in herbs and spices and fruits.

(-)-Epigallocatechin 3,4'-di-gallate

(2R,3R)-2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(-)-Epigallocatechin 3,4-di-gallate is found in tea. (-)-Epigallocatechin 3,4-di-gallate is isolated from tea (Thea sinensis). Isolated from tea (Thea sinensis). Epigallocatechin 3,4-digallate is found in tea.

Quercetin 3-(3-p-coumaroylglucoside)

2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid

C30H26O14 (610.1322)

Quercetin 3-(3-p-coumaroylglucoside) is isolated from Pinus sylvestris (Scotch pine). Isolated from Pinus sylvestris (Scotch pine)

Saprisartan

1-({3-bromo-2-[2-(trifluoromethanesulphonamido)phenyl]-1-benzofuran-5-yl}methyl)-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboximidic acid

C25H22BrF3N4O4S (610.0497)

Saprisartan is an AT1 receptor antagonist. It is based on medications of losartans prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism.(10579749) C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Quercetin 3-O-xylosyl-glucuronide

(2S,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl (2S,3S,4S,5R,6S)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H26O17 (610.117)

Quercetin 3-o-xylosyl-glucuronide is a member of the class of compounds known as flavonoid-3-o-glucuronides. Flavonoid-3-o-glucuronides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid at the C3-position. Quercetin 3-o-xylosyl-glucuronide is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Quercetin 3-o-xylosyl-glucuronide can be found in a number of food items such as summer grape, common grape, rubus (blackberry, raspberry), and highbush blueberry, which makes quercetin 3-o-xylosyl-glucuronide a potential biomarker for the consumption of these food products.

Prodelphinidin B1

(2R,3S)-8-[(2R,3R,4R)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

Prodelphinidin b1 is a member of the class of compounds known as biflavonoids and polyflavonoids. Biflavonoids and polyflavonoids are organic compounds containing at least two flavan/flavone units. These units are usually linked through CC or C-O-C bonds. Some examples include C2-O-C3, C2-O-C4, C3-C3, and C6-C8. Prodelphinidin b1 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Prodelphinidin b1 can be found in guava, which makes prodelphinidin b1 a potential biomarker for the consumption of this food product.

2-trans-Caffeoylisoorientin

5,7,3,4-Tetrahydroxyflavone 6-C- (2"-caffeylglucoside)

C30H26O14 (610.1322)

6)-gallocatechin

Gallocatechin-(4alpha-

C30H26O14 (610.1322)

Dolabellin

C24H32Cl2N2O8S2 (610.0977)

Quercetin 3-(2-p-coumarylglucoside)

[(2S,3R,5S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

Orientin 7-O-caffeate

2- (3,4-Dihydroxyphenyl) -8- (beta-D-glucopyranosyl) -7- [ 3- (3,4-dihydroxyphenyl) acryloyloxy ] -5-hydroxy-4H-1-benzopyran-4-one

C30H26O14 (610.1322)

Orientin 2'-O-caffeate

3,4,5,7-Tetrahydroxy-8- [ 2-O- [ 3- (3,4-dihydroxyphenyl) propenoyl ] -beta-D-glucopyranosyl ] flavone

C30H26O14 (610.1322)

Prodelphinidin B3

Gallocatechin-(4alpha-

C30H26O14 (610.1322)

Prodelphinidin B2

Epigallocatechin-(4beta-

C30H26O14 (610.1322)

Quercetin 3-(3-p-coumarylglucoside)

C30H26O14 (610.1322)

Prodelphinidin B5

C30H26O14 (610.1322)

Epigallocatechin 5,7,-di-O-gallate

(2R,3R) -3,5,7,3,4,5-Hexahydroxyflavan 5,7,-di-O-gallate

C29H22O15 (610.0959)

Gallocatechin 7,3-di-O-gallate

(2R,3S) -3,5,7,3,4,5-Hexahydroxyflavan 7,3-di-O-gallate

C29H22O15 (610.0959)

helichrysoside

2- (3,4-Dihydroxyphenyl) -5,7-dihydroxy-3- [ 6-O- [ (E) -3- (4-hydroxyphenyl) -1-oxo-2-propenyl ] -beta-D-glucopyranosyloxy ] -4H-1-benzopyran-4-one

C30H26O14 (610.1322)

Epigallocatechin 3,3,-di-O-gallate

(2R,3R) -3,5,7,3,4,5-Hexahydroxyflavan 3,3,-di-O-gallate

C29H22O15 (610.0959)

Isoorientin 6'-O-caffeate

3,4,5,7-Tetrahydroxy-6- [ 6-O- [ 3- (3,4-dihydroxyphenyl) acryloyl ] -beta-D-glucopyranosyl ] flavone

C30H26O14 (610.1322)

quercetin 3-O-(4\'-O-p-coumaroyl)-glucoside

quercetin 3-O-(4\"-O-p-coumaroyl)-glucoside

C30H26O14 (610.1322)

Epigallocatechin 3,5-Digallate_major

C29H22O15 (610.0959)

EPIGALLOCATECHIN 3,5-DIGALLATE

C29H22O15 (610.0959)

Cyanidin 3-(6-caffeylglucoside)

C30H26O14 (610.1322)

Delphinidin 3-(6-p-coumarylglucoside)

C30H26O14 (610.1322)

Epigallocatechin 3,5,-di-O-gallate

C29H22O15 (610.0959)

Epigallocatechin 3,4,-di-O-gallate

C29H22O15 (610.0959)

Gallocatechin 7,4-di-O-gallate

C29H22O15 (610.0959)

Isoorientin 6-O-caffeate

C30H26O14 (610.1322)

Kaempferol 3-(6-caffeoylglucoside)

C30H26O14 (610.1322)

Quercetin 3- (3-p-coumarylglucoside)

[(2S,3R,5R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

Cyanidin 3-(6-p-caffeoyl)glucoside

C30H26O14 (610.1322)

Delphinidin 3-(6-p-coumaroyl)glucoside

C30H26O14 (610.1322)

Saprisartan

1-({3-bromo-2-[2-(trifluoromethane)sulfonamidophenyl]-1-benzofuran-5-yl}methyl)-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide

C25H22BrF3N4O4S (610.0497)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

6''-O-Caffeoylastragalin

(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

6''-Caffeoylisoorientin

{6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-6-yl]-3,4,5-trihydroxyoxan-2-yl}methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

Quercetin 3-(3-p-coumaroylglucoside)

2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

Prodelphinidin B

8-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

Theasinensin C

2-{3,4,5-trihydroxy-2-[2,3,4-trihydroxy-6-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)phenyl]phenyl}-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

Rhaunoside G

Luteolin-7-O-(2-O-caffeoyl)-beta-D-glucopyranoside

C30H26O14 (610.1322)

Bis(2-Ethylhexyl) Chlorendate

C25H36Cl6O4 (610.0745)

Calcium Glubionate

C18H34CaO20 (610.1269)

1H,1H,2H,2H-PERFLUORODECYLTRIETHOXYSILANE

C16H19F17O3Si (610.0832)

silicon phthalocyanine dichloride

C32H16Cl2N8Si (610.0644)

Vat Red 32

C36H16Cl2N2O4 (610.0487)

CHLORO ALUMINUM CHLORO PHTHALOYANINE

C32H17AlCl2N8 (610.0769)

Rivaroxaban Impurity 12

C25H24Cl2N4O6S2 (610.0514)

quercetin 3-O-(3-O-p-coumaroyl)-glucoside

C30H26O14 (610.1322)

quercetin 3-O-(4-O-p-coumaroyl)-glucoside

C30H26O14 (610.1322)

(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-[(N-acetyl-S-arsono-L-cysteinyl)amino]-2-deoxy-alpha-D-glucopyranoside

C17H31AsN2O15S (610.0661)

[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

Quercetin 3-O-xylosyl-glucuronide

C26H26O17 (610.117)

[(3S,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

c-di-UMP

C18H20N4O16P2-2 (610.035)

CID 13917529

C30H26O14 (610.1322)

6-[5-[3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-4-oxochromen-2-yl]-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H26O17 (610.117)

[6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

6-Caffeoylisoorientin

C30H26O14 (610.1322)

6-O-Caffeoylastragalin

C30H26O14 (610.1322)

Prodelphinidin B4

Gallocatechin-(4alpha->8)-epigallocatechin

C30H26O14 (610.1322)

2-{[5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl 3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

{3,4,5-trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]oxan-2-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-7-hydroxy-5-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(2r,3s,4s)-4-[(2r,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

8-{[9-carboxy-4-(methoxycarbonyl)phenazin-2-yl]sulfanyl}-9-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C30H18N4O9S (610.0794)

(6-{[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(2r,3s,4r)-4-[(2r,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-6-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

{[(2r,3r,4s,5s,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]oxy}methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(2r,3s,4s,5r,6s)-6-{[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

4-[3,5,7-trihydroxy-2-(2,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)oxy]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(2r,3s,4r)-4-[(2s,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-6-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(2s,3r,4s,5s,6r)-2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

5-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

4-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

8-hydroxy-5-methyl-7-(methylsulfanyl)-3,4,6-trioxo-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-9,12-dien-14-yl 3-(5-formyl-2-methoxyphenoxy)-4-methoxybenzoate

C29H26N2O11S (610.1257)

[(2s,3s,4r,5s,6r)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(2s,3r,4s,5s,6s)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(2s,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1-benzopyran-3,4,5,7-tetrol

C30H26O14 (610.1322)

(2s,3r,4s,5s,6r)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(1s,7r,8r,14s)-8-hydroxy-5-methyl-7-(methylsulfanyl)-3,4,6-trioxo-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-9,12-dien-14-yl 3-(5-formyl-2-methoxyphenoxy)-4-methoxybenzoate

C29H26N2O11S (610.1257)

6,6'-bis[(2r,3r)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-2-yl]-[1,1'-biphenyl]-2,2',3,3',4,4'-hexol

C30H26O14 (610.1322)

4-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-6-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

(2r,3r,4r)-4-[(2r,3r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

(2s,3r,4s,5r,6r)-3,5-dihydroxy-2-{[7-hydroxy-5-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxy}-6-(hydroxymethyl)oxan-4-yl 3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

methyl 2-[1-({7,7-dichloro-3-[2-(1,2-dihydroxyethyl)-1,3-thiazole-4-carbonyloxy]-2-methyloctanoyl}oxy)-2-methylpropyl]-1,3-thiazole-4-carboxylate

C24H32Cl2N2O8S2 (610.0977)

[(2r,3s,4r,5r,6s)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

6,7,13-trihydroxy-14-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

6,7,13-trihydroxy-14-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C26H26O17 (610.117)

(2s,3r,4s,5s,6r)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(2r,3s,4s,5r)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

6,7,13-trihydroxy-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

6,7,13-trihydroxy-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C26H26O17 (610.117)

2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(2s,3r,4r,5r,6s)-2-{[5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(2r,3s)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

4-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

(2r,3r,4r)-4-[(2r,3r)-3,5,7-trihydroxy-2-(2,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-4-oxochromen-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

(2r,3r,4r)-4-[(2r,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C30H26O14 (610.1322)

4-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

{6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]-3,4,5-trihydroxyoxan-2-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

5-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

2-{[5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C30H26O14 (610.1322)

7,10,14-trihydroxy-13-methyl-6-{7,10,14-trihydroxy-13-methyl-9,15-dioxo-2,16-dioxatetracyclo[9.3.2.0¹,¹⁰.0³,⁸]hexadeca-3,5,7-trien-6-yl}-2,16-dioxatetracyclo[9.3.2.0¹,¹⁰.0³,⁸]hexadeca-3,5,7-triene-9,15-dione

7,10,14-trihydroxy-13-methyl-6-{7,10,14-trihydroxy-13-methyl-9,15-dioxo-2,16-dioxatetracyclo[9.3.2.0¹,¹⁰.0³,⁸]hexadeca-3,5,7-trien-6-yl}-2,16-dioxatetracyclo[9.3.2.0¹,¹⁰.0³,⁸]hexadeca-3,5,7-triene-9,15-dione

C30H26O14 (610.1322)